Media Release: 20 October 2017
In Australia it is estimated 1.2 million people are affected by osteoporosis. It is a disease that does not just affect women. Men account for up to 30% of all fractures related to osteoporosis and their associated costs. The cost of fractures is the largest component cost of poor bone health in Australia, presenting a serious burden to the healthcare system.
To mark World Osteoporosis Day, the Garvan Institute of Medical Research is hosting an Osteoporosis Seminar. Open to the public, the seminar provides attendees with the opportunity to ask questions, engage with researchers and learn about the latest developments around this major health issue. Speakers include Professor Peter Croucher, Garvan’s Bone Biology Division Head; Professor Markus Seibel, Director of the Bone Research Program: ANZAC Research Institute, and Professor John Eisman, Lab Head: Osteoporosis & Translational Research at Garvan. The seminar will be live streamed on Garvan’s social channels.
Broadening the awareness of the importance of bone health, improving the bone health of the Australian population, and the outcomes for people with osteoporosis is integral to the vision and recommendations of the Osteoporosis National Action Plan. Recommendations currently being implemented by member organisations focus on prevention, treatment, impact and cure and a national strategy for research into curing osteoporosis.
Garvan Research Foundation CEO, Mr Andrew Giles said, “Osteoporosis is a national issue, and Garvan is playing an important role in building awareness of the disease, and support for research. It is encouraging to see our activities, and those of others like Osteoporosis Australia, starting to make inroads be it at State and Federal levels, amongst GPs or at a broader community level. We are seeing, and will continue to see, great initiatives underway.”
Garvan’s World Osteoporosis Day Seminar is timely, following a bi-partisan Federal Ministerial roundtable on fracture prevention hosted by Osteoporosis Australia in Canberra this week. Professor Peter Croucher and Professor John Eisman attended the round table to review the impact of osteoporosis in Australia and investigate strategies for fracture prevention.
Mr Giles adds, “An integrated national approach is critical to improving care while reducing the health care and individual human costs of osteoporosis.”
World Osteoporosis Day is dedicated to raising global awareness of the prevention, diagnosis and treatment of osteoporosis. The day aims to put osteoporosis and fracture prevention on the global health agenda by reaching out to healthcare professionals, policy makers and members of the public. The 2017 theme for WOD is 'Love your bones - Protect your future'. Garvan and Osteoporosis Australia are encouraging Aussies to visit Know Your Bones www.knowyourbones.org.au, an online self-assessment tool to better understand their risk and discuss with their GP if required.
To download a copy of the Osteoporosis National Action Plan, visit www.garvan.org.au
ABOUT THE GARVAN INSTITUTE OF MEDICAL RESEARCH
The Garvan Institute of Medical Research (Garvan) was founded in 1963 and is a world leader in gene-based medical research. It is a multi-disciplinary facility, pioneering study into some of the most widespread diseases of today (cancer, osteoporosis, diabetes, neurological and immunological disorders). Garvan researchers investigate the origins, diagnostic markers and most effective treatments of disease with the ultimate aim of prevention and cure. One of Garvan’s greatest strengths is the extent of active cross-collaboration between the research areas and the consequent innovation this drives.
ABOUT THE GARVAN RESEARCH FOUNDATION
The Garvan Research Foundation was established in 1981 to provide fundraising and marketing support to Garvan’s medical research programs In addition to its fundraising activities, the Foundation's activities have since expanded to support Garvan with a Public Engagement Program. This initiative aims to increase understanding of the need for and importance of, Garvan's medical research across the broader community.
Issued by QUAY Communications on behalf of Garvan Research Foundation
For more information please call;
- Quay Communications, Emma Norgrove, M: 0499 688 001, T: 02 9386 9161
- Quay Communications, Cheryl Pettinau, M: 0424 157 714, T: 02 9386 9161
 Henry M, Pasco JA, Nicolson GC, et al. Prevalence of osteoporosis in Australian men and women: Geelong Osteoporosis Study. Med J Australia 2011;195:321-322.
 Osteoporosis Australia, Facts & Figures